Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer [Phase 1]
Phase 1 trial assessing bortezomib with cetuximab and radiation therapy, with or without cisplatin, in stage IV head and neck cancer; status…
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating muscle composition and swallowing function in head and neck cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer [EARLY_Phase 1]
An early Phase 1 trial evaluating angiogenic and EGFR blockade in combination with curative chemoradiation for advanced head and neck cancer…
-
FDA approval · 2011-08-26FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC, resulting in an updated regulatory status for the …
-
CLINICAL_TRIALS trial_result · 2011-08-24Clinical Trial Update: Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin [Phase 1]
Phase 1 study of photodynamic therapy for skin cancers and solid tumors metastatic to the skin has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-08-24Clinical Trial Update: Study of Chemo-Immunotherapy in Head and Neck Cancer Patients [Phase 1]
A Phase 1 clinical trial update investigating chemo-immunotherapy for head and neck cancer, with current status not disclosed.
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery [Phase 4]
Phase 4 clinical trial update examining the effects of vasopressor pressors on graft blood flow after free tissue transfer surgery in patien…
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Nutrition and Resistance Training in Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating nutrition and resistance training in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating metronomic tegafur/uracil chemotherapy for head and neck squamous cell carcinoma. The current statu…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]
Clinical trial update reporting completion of SWOG S0216 Phase 2 study evaluating the combination of chemotherapy with radiotherapy for stag…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Randomized Controlled Trial of Bipolar Versus Ultrasonic Hemostasis Techniques in Thyroidectomy [NA]
A randomized trial comparing bipolar versus ultrasonic hemostasis techniques during thyroidectomy was completed, assessing differences in su…
-
FDA approval · 2011-06-29FDA Approved: DOCETAXEL — Original Application (Baxter Healthcare Corporation)
FDA approved the original application for docetaxel by Baxter Healthcare Corporation, marking its initial U.S. approval as a cancer therapy.…
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer. [Phase 3]
Phase 3 clinical trial update comparing 3D conformal radiotherapy (3DCRT) with image-guided radiotherapy (IGRT) and analyzing early response…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial evaluating radioimmunotherapy with or without chemotherapy, followed by peripheral stem cell tr…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 3]
Amgen completed a Phase 3 trial evaluating panitumumab for recurrent and/or metastatic head and neck cancer; trial results were posted in 20…
-
CLINICAL_TRIALS research · 2011-06-08Clinical Trial Update: Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer
A completed clinical trial explored whether contact allergies to dental metal may be a risk factor for oral cancer, including head and neck …
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial assessing the combination of cetuximab with stereotactic radiation therapy for patients with recurrent head and neck …
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy [NA]
This clinical trial update notes the completed status of a study assessing PET imaging in head and neck cancer patients treated with 3D-conf…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer [Phase 2]
A Phase 2 trial evaluating isotretinoin in combination with interferon for recurrent cancers has completed, including cervical, esophageal, …
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors [Phase 1]
A Phase 1 clinical trial update evaluating the combination of paclitaxel and bortezomib in patients with metastatic or unresectable malignan…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck [Phase 2]
Phase 2 trial of docetaxel plus capecitabine as first-line treatment for metastatic squamous cell carcinoma of the head and neck was termina…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer [Phase 2]
An early-phase II trial evaluating weekly paclitaxel (BMS-181339) in patients with advanced or recurrent head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer [Phase 2]
This is a Phase 2 trial of celecoxib as adjuvant biologic therapy in patients with head and neck cancer and lung cancer. The study was termi…
-
CLINICAL_TRIALS research · 2011-04-18Clinical Trial Update: Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients [Phase 3]
A Phase 3 clinical trial comparing oral pilocarpine (Salagen) to a submandibular salivary gland transfer protocol for preventing radiation-i…
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: A Study for Patients With Head and Neck Cancer [Phase 3]
A Phase 3 clinical trial in head and neck cancer sponsored by Eli Lilly has completed with results posted in 2011.